Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders

FA Iannotti, V Di Marzo, S Petrosino - Progress in lipid research, 2016 - Elsevier
The endocannabinoid system (ECS) is composed of two G protein-coupled receptors
(GPCRs), the cannabinoid CB1 and CB2 receptors, and the two main endogenous lipid …

Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites

C Turcotte, F Chouinard, JS Lefebvre… - Journal of Leucocyte …, 2015 - academic.oup.com
Arachidonoyl-glycerol (2-AG) and arachidonyl-ethanolamide (AEA) are endocannabinoids
that have been implicated in many physiologic disorders, including obesity, metabolic …

Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling …

CA Rouzer, LJ Marnett - Chemical reviews, 2011 - ACS Publications
The discovery of the cannabinoid receptors CB1 and CB2 in 19881, 2 and 1990, 3
respectively, and of the endogenous cannabinoid ligands (endocannabinoids) …

The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation

V Di Marzo - Pharmacological research, 2009 - Elsevier
The endocannabinoid signalling system includes:(1) at least two G-protein-coupled
receptors, known as the cannabinoid CB1 and CB2 receptors and discovered following …

Endocannabinoids: synthesis and degradation

V Di Marzo - Reviews of Physiology Biochemistry and …, 2008 - Springer
Endocannabinoids were defined in 1995 as endogenous agonists of cannabinoid receptors,
ie of the G protein-coupled receptors for cannabis's psychoactive principle, Δ 9 …

Biochemistry and pharmacology of endovanilloids

K Starowicz, S Nigam, V Di Marzo - Pharmacology & therapeutics, 2007 - Elsevier
Endovanilloids are defined as endogenous ligands and activators of transient receptor
potential (TRP) vanilloid type 1 (TRPV1) channels. The first endovanilloid to be identified …

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

DM Lambert, CJ Fowler - Journal of medicinal chemistry, 2005 - ACS Publications
As far as can be ascertained from archeological sources, preparations of the hemp
Cannabis sativa L. were widely used by humans for either therapeutic or ritual purposes in …

An introduction to the endocannabinoid system: from the early to the latest concepts

L De Petrocellis, V Di Marzo - … practice & research Clinical endocrinology & …, 2009 - Elsevier
A rather complex and pleiotropic endogenous signalling system was discovered in the late
1990s, starting from studies on the mechanism of action of Δ9-tetrahydrocannabinol, the …

Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling

C Manca, B Boubertakh, N Leblanc, T Deschênes… - Journal of lipid …, 2020 - ASBMB
The gut microbiota is a unique ecosystem of microorganisms interacting with the host
through several biochemical mechanisms. The endocannabinoidome (eCBome), a complex …

Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient …

L De Petrocellis, V Di Marzo - Journal of Neuroimmune Pharmacology, 2010 - Springer
The molecular mechanism of action of Δ 9-tetrahydrocannabinol (THC), the psychotropic
constituent of Cannabis, has been a puzzle during the three decades separating its …